Japan Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033
일본 재조합 단백질 시장 시장 규모는 2024년에 2억 6,570만 달러에 달했습니다. IMARC Group은 2025-2033년간 성장률(CAGR)은 9%를 나타내고, 2033년에는 5억 7,660만 달러에 달할 것으로 예측하고 있습니다. 모노클로널 항체, 백신, 치료용 단백질 등, 암, 자가면역질환, 감염증 등 다양한 질환 치료에 사용되게 되어 있는 바이오의약품의 개발이 시장을 촉진하고 있습니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문
- 일본 재조합 단백질 시장의 지금까지 실적과 향후 수년간 실적은?
- COVID-19일본 재조합 단백질 시장에 대한 영향은?
- 일본 재조합 단백질 시장의 제품별 구성비는?
- 일본 재조합 단백질 시장의 용도별 분석은?
- 일본 재조합 단백질 시장의 최종사용자별 분석은?
- 일본 재조합 단백질 시장의 밸류체인에는 어떤 단계가 있는가?
- 일본에서 재조합 단백질의 주요촉진요인과 과제는 무엇인가?
- 일본 재조합 단백질 시장의 구조와 주요 기업은?
- 일본 재조합 단백질 시장에서 경쟁의 정도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 개요
제4장 일본의 재조합 단백질 시장 - 서론
제5장 일본의 재조합 단백질 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033년)
제6장 일본의 재조합 단백질 시장 - 제품별 분석
제7장 일본의 재조합 단백질 시장 - 용도별 분석
- Drug Discovery and Development
- 학술연구
- 바이오테크놀러지 연구
- 바이오의약품 제조
- 기타
제8장 일본의 재조합 단백질 시장 - 최종사용자별 분석
- 제약 및 바이오의약품 기업
- 바이오테크놀러지 기업
- 학술연구기관
- 계약연구기관
- 기타
제9장 일본의 재조합 단백질 시장 - 경쟁 구도
- 개요
- 시장 구조
- 시장 기업의 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제10장 주요 기업의 개요
제11장 일본의 재조합 단백질 시장 - 업계 분석
- 성장 촉진요인 및 억제요인, 기회
- Porter의 산업 분석
- 밸류체인 분석
제12장 부록
LSH
Japan recombinant protein market size reached USD 265.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 576.6 Million by 2033, exhibiting a growth rate (CAGR) of 9% during 2025-2033. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.
Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.
Japan Recombinant Protein Market Trends:
Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.
Japan Recombinant Protein Market Segmentation:
Product Insights:
- Antibodies
- Hormones
- Growth Factors
- Cytokines
- Others
Application Insights:
- Drug Discovery and Development
- Academic Research
- Biotechnology Research
- Biopharmaceutical Production
- Others
End User Insights:
- Pharmaceutical and Biopharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organization
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan recombinant protein market?
- What is the breakup of the Japan recombinant protein market on the basis of product?
- What is the breakup of the Japan recombinant protein market on the basis of application?
- What is the breakup of the Japan recombinant protein market on the basis of end user?
- What are the various stages in the value chain of the Japan recombinant protein market?
- What are the key driving factors and challenges in the Japan recombinant protein?
- What is the structure of the Japan recombinant protein market and who are the key players?
- What is the degree of competition in the Japan recombinant protein market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Recombinant Protein Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Recombinant Protein Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Recombinant Protein Market - Breakup by Product
- 6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Hormones
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Growth Factors
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Cytokines
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
- 6.5 Others
- 6.5.1 Historical and Current Market Trends (2019-2024)
- 6.5.2 Market Forecast (2025-2033)
7 Japan Recombinant Protein Market - Breakup by Application
- 7.1 Drug Discovery and Development
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Academic Research
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Biotechnology Research
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 Biopharmaceutical Production
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
- 7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)
8 Japan Recombinant Protein Market - Breakup by End User
- 8.1 Pharmaceutical and Biopharmaceutical Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Biotechnology Companies
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Academic and Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
- 8.4 Contract Research Organization
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
- 8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)
9 Japan Recombinant Protein Market - Competitive Landscape
- 9.1 Overview
- 9.2 Market Structure
- 9.3 Market Player Positioning
- 9.4 Top Winning Strategies
- 9.5 Competitive Dashboard
- 9.6 Company Evaluation Quadrant
10 Profiles of Key Players
- 10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
- 10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
- 10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
- 10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
- 10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events
11 Japan Recombinant Protein Market - Industry Analysis
- 11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
- 11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
- 11.3 Value Chain Analysis
12 Appendix
